Data / Form D filings / Ensho Therapeutics, Inc.
Ensho Therapeutics, Inc.: Form D filing
Ensho Therapeutics, Inc., a biotechnology company in Woodcliff Lake, NJ, filed a Form D with the SEC in 2026. The latest, on October 15, 2026, reports $7.3 million sold of a $15.6 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 50 Tice Boulevard Suite 340 - #1005, Woodcliff Lake, NJ, 07677
- Phone
- (973) 475-8970
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2032849
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15 | New notice | $15,604,179 | $7,281,948 | $8,322,231 | 7 | Oct 2 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Danielle Fry | Executive Officer | |
| Arash Rassoulpour | Director | |
| Carlos Solorzano | Director | |
| Eric Pham | Director | |
| Gerhard Hagn | Director | |
| Neena Bitritto-Garg | Director | |
| Tariq Kassum | Director |
Other biotechnology companies in New Jersey that filed recently
- Xenon Ophthalmics Inc $3.3 million · Oct 6
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2
Every Form D from the week of Oct 12 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ensho Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.